PATENT CLAIM ANALYSIS

Application Number: 16256908
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["702", "019000"]

Abstract:
Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.

Claim (Index 25):
The method of claim  6 , wherein said determining step further comprises normalizing the expression of the genes ASF1B, ASPM, BIRC5, BUB1B, Cl8orf24, CDC2, CDC20, CDCA3, CDCA8, CDKN3, CENPF, CENPM, CEP55, DLGAP5, DTL, FOXM1, KIAA0101, KIF11, KIF20A, MCM10, NUSAP1, ORC6L, PBK, PLK1, PRC1, PTTG1, RAD51, RAD54L, RRM2, TK1 and TOP2A using the expression of the housekeeping genes.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.16667
- Patent Class: 702.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13819963', '15919394', '15588458', '12812215', '13985470']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.2261536697894136
- 35 USC 102 Novelty (BERT): 0.7896956841922739
- Combined Prediction Score: 0.2825078712296996
- Mean Citation Score: 581.3547440000001
- Max Citation Score: 975.82794
- Similarity Product: 953.8607229883504

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test